SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-012136
Filing Date
2023-08-11
Accepted
2023-08-11 16:10:53
Documents
1
Period of Report
2023-08-11

Document Format Files

Seq Description Document Type Size
1 form4-08112023_040826.html 4  
1 form4-08112023_040826.xml 4 7339
  Complete submission text file 0001415889-23-012136.txt   8707
Mailing Address AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Cole Douglas G. (Reporting) CIK: 0001486373 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 231164184

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations